Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 360.00
-9.20 (-2.49%)
Apr 21, 2026, 3:29 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 141.24 billion as of April 21, 2026. Its market cap has decreased by -50.15% in one year.
Market Cap
141.24B
Enterprise Value
143.12B
Revenue
10.79B
Ranking
n/a
PE Ratio
157.13
Stock Price
360.00
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 141.24B, an increase of 418,958.86%. That is a compound annual growth rate of 290.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 141.24B | -30.16% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 317.01B |
| Gland Pharma | 296.13B |
| Wockhardt | 226.73B |
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 200.26B |
| Piramal Pharma | 197.65B |
| Alembic Pharmaceuticals | 154.25B |
| Alivus Life Sciences | 131.28B |